Content about Sandoz

August 26, 2010
FDA approves new use of first U.S.-approved follow-on biologic

The FDA approved Sandoz Omnitrope (somatropin [rDNA origin]) as a treatment for idiopathic short stature,...

August 23, 2010
Sanofi-Aventis suing Sandoz to prevent generic blood thinner from reaching the market

French drug maker Sanofi-Aventis is suing to stop Sandoz’ generic version of its blood thinner...

July 22, 2010
Sandoz first to receive FDA approval for Lovenox generic

The Food and Drug Administration has approved the first generic version of a Sanofi-Aventis injected...

SILVER SPRING, Md. The Food and Drug Administration has approved the first generic version of a Sanofi-Aventis injected drug used to treat deep vein thrombosis, the agency said Friday.

 

The FDA approved generic enoxaparin sodium, a version of Sanofi’s Lovenox, developed under a collaboration between Momenta Pharmaceuticals and Sandoz, the generics division of Swiss drug maker Novartis.

 

 

July 15, 2010
Novartis reports positive Q2

Sales and profits grew significantly for Swiss drug maker Novartis, with significant growth across divisions,...

July 13, 2010
Teva launches generic Amerge

Teva Pharmaceuticals has launched a drug for treating migraine headaches, the generic drug maker said....

NORTH WALES, Pa. Teva Pharmaceuticals has launched a drug for treating migraine headaches, the generic drug maker said.

 

Teva announced the launch of naratriptan tablets in the 1 mg and 2.5-mg strengths. The tablets are a generic version of GlaxoSmithKline’s Amerge. The drug is used to treat acute migraine attacks in adults with or without visual disturbances preceding the attacks known as aura.

 

 

July 11, 2010
Sandoz launches generic Amerge

Sandoz has launched a generic drug for treating migraine headaches, the generics arm of Swiss...

PRINCETON, N.J. Sandoz has launched a generic drug for treating migraine headaches, the generics arm of Swiss drug maker Novartis said Monday.

 

Sandoz launched naratriptan hydrochloride tablets in the 2.5-mg strength, a generic version of GlaxoSmithKline’s Amerge. The tablets are used for treating acute migraine attacks in adults with or without visual disturbances that occur before the onset of the headache, also known as aura. Studies have indicated that around 12% of Americans have migraine attacks.

 

 

July 6, 2010
Sandoz launches generic Exelon

Sandoz has launched a version of a drug for treating dementia, the generics arm of...

June 29, 2010
Expect to see growth from Novartis, Datamonitor says

Some of the strongest growth among large drug companies may come from Swiss drug maker...

June 28, 2010
Actavis names new CEO

Icelandic generic drug maker Actavis has appointed a new chief executive, Actavis said last week....

June 27, 2010
FDA approves expanded use of Omnitrope

The Food and Drug Administrations has approved two new uses for what remains, thus far,...

June 10, 2010
Sandoz opens new generics development site

Sandoz has opened what it calls a key site for the development of generic drugs...

June 2, 2010
Sandoz closes Oriel Therapeutics deal

Sandoz has acquired privately owned U.S. drug maker Oriel Therapeutics, the generics arm of Novartis...

May 19, 2010
Sandoz to market generic Skelaxin

Sandoz has launched a generic version of a muscle relaxant, the generics arm of Swiss...

May 16, 2010
Reporters Notebook

Sandoz got its hands on a collection of generic drug candidates as it agreed to...

May 4, 2010
Sandoz launches generic Augmentin XR

Sandoz has launched a generic antibiotic for pneumonia and acute sinus infections, the generics arm...

May 3, 2010
Sandoz launches generic Flomax, Vancocin

Sandoz has launched a generic version of a prostate drug, the generics arm of Novartis...

January 25, 2010
Novartis' Vasella to focus on being chairman, bows out from CEO role

Daniel Vasella will step down as CEO of Novartis to focus on his position as...

January 25, 2010
Sandoz affirms its generic anti-clotting drug will be approved

Sandoz is “confident” that it will win approval for a generic anti-clotting drug, according to...

January 20, 2010
Sandoz launches generic mental disorder treatment

Sandoz has launched a generic version of a drug for schizophrenia and bipolar disorder, the...